Dr. Nadler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
44 Binney St
Smith Building, Suite 339
Boston, MA 02115Phone+1 617-632-3331- Is this information wrong?
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1977 - 1980
- New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1973 - 1975
- Harvard Medical SchoolClass of 1973
Certifications & Licensure
- MA State Medical License 1977 - 2025
- ME State Medical License Active through 1984
- MD State Medical License 1975 - 1979
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1989
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- 4 citationsDevelopment of a Coronavirus Disease 2019 (COVID-19) Application Ontology for the Accrual to Clinical Trials (ACT) networkShyam Visweswaran, Malarkodi J Samayamuthu, Michele I. Morris, Griffin M. Weber, Douglas MacFadden, Philip Trevvett, Jeffrey G. Klann, Vivian S. Gainer, Barbara Benoit...> ;JAMIA Open. 2021 Apr 19
- Development of a COVID-19 Application Ontology for the ACT NetworkShyam Visweswaran, Malarkodi J Samayamuthu, Michele I. Morris, Griffin M. Weber, Douglas MacFadden, Philip Trevvett, Jeffrey G. Klann, Vivian S. Gainer, Barbara Benoit...> ;Medrxiv. 2021 Mar 24
- 4 citationsIndividual and cumulative health afflictions are associated with greater impairment in physical and mental function in former professional American style football playersAdam S. Tenforde, Bryan Cortez, Elaine Coughlan-Gifford, Rachel Grashow, Jillian Baker, Aaron L. Baggish, Alvaro Pascual-Leone, Lee M. Nadler, Frank E. Speizer, Herman...> ;PM & R. 2021 Feb 28
- Join now to see all
Press Mentions
- Growing Value and Opportunity for Integrative Oncology in Hospital SettingsSeptember 10th, 2019
- Seasoned Scientific Experts and Strategic Pharmaceutical Industry Veterans Join Cerenis’ Scientific Advisory Board in OncologyMay 7th, 2018
- Des Decideurs, Veterans De L’industrie Pharmaceutique Et Des Experts De Renommee Mondiale Se Joignent Au Conseil Scientifique Oncologie De CerenisMay 2nd, 2018
- Join now to see all
Grant Support
- Harvard Clinical And Translational Science Center (UL1)National Center For Research Resources2008–2011
- Harvard Clinical And Translational Science Center (TL1)National Center For Research Resources2008–2011
- Harvard Clinical And Translational Science Center (KL2)National Center For Research Resources2008–2011
- CTSA Infrastructure For Pediatric ResearchNational Center For Research Resources2008–2011
- CTSA Infrastructure For Clinical TrialsNational Center For Research Resources2008–2011
- CTSA Infrastructure For AIDS ResearchNational Center For Research Resources2008–2011
- Networking Research Resources Across AmericaNational Center For Research Resources2009–2010
- Specific Control Of Donor Anti-Host AlloreactiviyNational Cancer Institute2008
- Administrative CoreNational Cancer Institute2008
- Rebuilding Immunity For SurvivalNational Cancer Institute2006–2008
- Rebuilding Immunity For SurvivalNational Cancer Institute2003–2005
- T Cell Immunity In Germinal Center B Cell LymphomaNational Cancer Institute2001–2002
- Translational Therapeutic Strategies In Acute Lymphocytic LeukemiaNational Cancer Institute2000–2002
- Antigen Specific Immunity In Multiple MyelomaNational Cancer Institute1998–2002
- Molecular Pathways Regulating T Cell Anergy To AlloantigenNational Institute Of Allergy And Infectious Diseases1997–2001
- Induction Of Host-Specific Tolerance In Allogenic BMTNational Institute Of Allergy And Infectious Diseases1997–2001
- Induction Of T Cell Mediated Tumor Specific Immunity Against Leukemia &LymphomaNational Cancer Institute1996–2001
- Selective Depletion Of T Cells From Donor Bone MarrowNational Heart, Lung, And Blood Institute1996–1999
- Selective Depletion Of T Cells From Donor Bone MarrowNational Heart, Lung, And Blood Institute1996–1997
- Novel Cd28/Ctla4 Counter-ReceptorsNational Cancer Institute1995–1997
- Induction Of Host-Specific Tolerance In Allogeneic BMTNational Institute Of Allergy And Infectious Diseases1993–1996
- Function Of The B7 Antigen On Normal/Neoplastic B CellsNational Cancer Institute1991–1994
- Characterization Of Human B-Cell Activation AntigensNational Cancer Institute1985–1990
Hospital Affiliations
- Brigham and Women's HospitalBoston, Massachusetts
- Dana-Farber Cancer InstituteBoston, Massachusetts
- Salem HospitalSalem, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: